330 Investigating the clinical safety, efficacy, and immune modulation of combined XL888 and pembrolizumab in metastatic gastrointestinal malignancies

• Mohammad Zaidi,
• Yuchen Zhang,
• Kavita Dhodapkar,
• Madhav Dhodapkar,
• Gregory Lesinski,
• Matthew Farren,
• Christina Wu,
• Rafi Ahmed,
• Cameron Herting,
• Deon Doxie,
• Michael Ware,
• Olatunji Alese,
• Walid Shaib,
• Mehmet Akce,
• Amanda Ruggieri,
• Juan Sarmiento,
• Shishir Maithel,
• Bassel El-rayes

Affiliations

Mohammad Zaidi

1Winship Cancer Institute of Emory University, Decatur, GA, USA

Yuchen Zhang

2Xi’an Jiaotong University, Shaanxi, China

Kavita Dhodapkar

3Emory University School of Medicine, Atlanta, GA, USA

Madhav Dhodapkar

1Winship Cancer Institute of Emory University, Decatur, GA, USA

Gregory Lesinski

1Winship Cancer Institute of Emory University, Decatur, GA, USA

Matthew Farren

1Winship Cancer Institute of Emory University, Decatur, GA, USA

Christina Wu

1Winship Cancer Institute of Emory University, Decatur, GA, USA

Rafi Ahmed

4Emory University, Atlanta, GA, USA

Cameron Herting

1Winship Cancer Institute of Emory University, Decatur, GA, USA

Deon Doxie

3Emory University School of Medicine, Atlanta, GA, USA

Michael Ware

1Winship Cancer Institute of Emory University, Decatur, GA, USA

Olatunji Alese

1Winship Cancer Institute of Emory University, Decatur, GA, USA

Walid Shaib

1Winship Cancer Institute of Emory University, Decatur, GA, USA

Mehmet Akce

1Winship Cancer Institute of Emory University, Decatur, GA, USA

Amanda Ruggieri

1Winship Cancer Institute of Emory University, Decatur, GA, USA

Juan Sarmiento

1Winship Cancer Institute of Emory University, Decatur, GA, USA

Shishir Maithel

1Winship Cancer Institute of Emory University, Decatur, GA, USA

Bassel El-rayes

1Winship Cancer Institute of Emory University, Decatur, GA, USA